medigraphic.com
Anales de Otorrinolaringología Mexicana

2004, Number 4

Next >>

Otorrinolaringología 2004; 49 (4)

Selective supraomohyoid neck dissection: technique and results

Ferbeyre-Binelfa L, Hernández-Herrera L, Cruz-González P, Correa-Pablos T

Language: Spanish
References: 45
Page: 9-31
PDF size: 187.42 Kb.


ABSTRACT

Background. Elective treatment of the neck in cancer of the oral cavity has changed over the last 25 years. The purpose of this study is to present the results of a retrospective study designed to compare standard supraomohyoid neck dissection to observation in the management of clinically negative neck (N0) in oral cancer patients. Patients and methods. A total of 105 patients seen at the National Institute of Oncology and Radiobiology in Havana, Cuba, between January 1990 and December 2000 were included in the study. All patients had previously untreated T0 to T4 N0 squamous cancer of the oral cavity; 73 patient necks received observation policy and 32 underwent selective supraomohyoid neck dissection. Results. The risk of tumour relapse was 1.23 times higher in patients with observation policy. Positive lymph nodes in the surgical specimen was predictive of a higher recurrence rate. The five years disease free survival for patients whose necks were treated was 69.05%, and for those who were observed 52.42%. Conclusions. Supraomohyoid neck dissection can be recommended as standard elective treatment for the N0 neck in oral cancer.


REFERENCES

  1. Byers RM. Modified neck dissection: a study of 967 cases from 1970 to 1980. J Surg 1985; 150: 414-21.

  2. Byers RM, Weber RS, Andrews T et al. Frequency and therapeutic implications of “skip metastases” in the neck from squamous carcinoma of the oral tongue. Head Neck 1997; 19: 14-9.

  3. Lindberg R. Distribution of cervical lymph node metastasis from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer 1972; 29: 1446-9.

  4. Shah JP. Patterns of cervical lynph node metastasis from squamous carcinoma of the upper aerodigestive tract. J Surg 1990; 160: 405-9.

  5. Shah JP, Medina JE, Shaha AR et al. Cervical lymph node metastasis. Curr Probl Surg 1993; 30 (3): 1-335.

  6. Crissman JD, Liu WY, Gluckman JL et al. Pronostic value of histopathologic parameters in squamous cell carcinoma of the oropharynx. Cancer 1984, 54: 2995-3001.

  7. Dos Santos CR, Filho JG, Magrin J et al. Involvement of level I neck lymph nodes in T3 T4 N1-N2c squamous carcinoma of the larynx. Ann Otol Rhinol Laryngol 2001; 110: 982–4.

  8. Ferlito A, Partridge M, Brennan JA, Hamakawa H. Lymph node micrometastasis in head and neck cancer: a review. Acta Otolaryngol 2001; 121: 660-5.

  9. Ferlito A, Rinaldo A, Robbins KT et al. Changing concepts in the surgical management of the cervical node metastasis. Oral Oncol 2003; 39: 429-35.

  10. Chiesa F, Tradati N, Calabrese L. Sentinel node biopsy, lymphatic pattern and selective neck dissection in oral cancer. Oral Dis 2001; 7 (5): 317-8.

  11. Taylor RJW, Sharma PK, Bradford CR et al. Sentinel node localization in oral cavity and oropharynx squamous cell cancer. Arch Otolaryngall Head Neck Surg 2001; 127 (8):970-4.

  12. Crile G. Excision of cancer of the head and neck. With special reference to the plan of dissection based on 132 patients. JAMA 1906; 47: 1780-6.

  13. Martin HE, Del Valle B, Ehrlich H, Cahan WG. Neck dissection. Cancer 1951; 4: 441-99.

  14. Suárez O. El problema de las metástasis linfáticas del cáncer de laringe e hipofaringe. Rev Otorrinolaringol 1963; 23: 83-99.

  15. Ferlito A, Gavilan J, Buckley JG et al. Functional neck dissection: fact and fiction. Head Neck 2001; 23: 804-8.

  16. Gavilan J, Herranz J, DeSanto LW, Gavilan C. Functional and selective neck dissection. Thieme, New York:, 2001 (in press).

  17. Houck JR, Medina JE. Management of cervical lymph nodes in squamous carcinomad of the head and neck. Semin Surg Oncol 1995; 11: 228-39.

  18. Andersen PE, Shah JP, Cambronero E, Spiro RH. The role of comprehensive neck dissection with preservation of the spinal accessory nerve in the clinically positive neck. J Surg 1994; 168: 499-502.

  19. Robbins KT, Medina JE, Wolfe GT et al. Standardizing neck dissection terminology. Official report of the Academy’s Committee for Head and Neck Surgery and Oncology. Arch Otolaryngol Head Neck Surg 1991; 117: 601-5.

  20. Wong RJ, Rinaldo A, Ferlito A, Shah JP. Occult cervical metastasis in head and neck cancer and its impact on therapy. Acta Otolaryngol 2002; 122 (1): 107- 14.

  21. Shear M, Hawkins DM, Farr HW. The prediction of lymph node metastases from oral squamous carcinoma. Cancer 1976; 37: 1901-7.

  22. Buckley JG, MacLennan K. Cervical node metastasis in laryngeal and hypopharyngeal cancer: a prospective analysis of prevalence and distribution. Head Neck 2000; 22: 380-5.

  23. Martinez-Gimeno C, Moro-Rodriguez E, Navarro-Vila C, Lopez-Varela C. Squamous cell carcinoma of the oral cavity: a clinicopathologic scoring system for evaluating risk of cervical lymph node metastasis. Laryngoscope 1995; 105:728-33.

  24. Ambrosch P, Kron M, Pradier O, Steiner W. Efficacy of selective neck dissection: a review of 503 cases of elective and therapeutic treatment of the neck in squamous cell carcinoma of the upper aerodigestive tract. Otolaryngol Head Neck Surg 2001; 124: 180-7.

  25. Hosal AS, Carrau RL, Johnson JT, Myers EN. Selective neck dissection in the management at the clinically node-negative neck. Laryngoscope 2000; 110 (12): 2037-40.

  26. Myers EN, Fagan JJ. Treatment of the N+ neck in squamous cell carcinoma of the upper aerodigestive tract. Otolaryngol Clin North Am 1998; 31 (4): 671-86.

  27. McGuirt WF, Johnson JT, Myers EN et al. Floor of mouth carcinoma: the management of clinically negative neck. Arch Otolaryngol Head Neck Surg 1995; 121: 278-82.

  28. Spiro JD, Spiro RH, Shah JP et al. Critical assessment of supraomohyoid neck dissection. J Surg 1988; 156: 286-9.

  29. Kerrebijn JD, Freeman JL, Irish JC et al. Supraomohyoid neck dissection. Is it diagnostic or therapeutic? Head Neck 1999; 21 (1): 39-42.

  30. Majoufre C, Faucher A, Loroche C et al. Supraomohyoid neck dissection in cancer of the oral cavity. J Surg 1999; 178 (1): 73-7.

  31. Kolli VR, Datta RV, Orner JB et al. The role of supraomohyoid neck dissection in patients with positive nodes. Arch Otolaryngol Head Neck Surg 2000; 126 (3): 413-6.

  32. Persky Ms, Lagmay VM. Treatment of the clinically negative neck in oral squamous cell carcinoma. Laryngoscope 1999; 109 (7, Pt 1): 1160-4.

  33. Clayman GL, Frank DK. Selective neck dissection of anatomically appropriate levels is as efficacious as modified radical neck dissection for elective treatment of the clinically negatice neck in patients with squamous cell carcinoma of the upper respiratory and digestive tracts. Arch Otolaryngol Head Neck Surg 1998; 124 (3): 348-52.

  34. Brazilian Head and Neck Cancer Study Group. End results of a prospective trial on elective lateral neck dissection vs. type III modified radical neck dissection in the management of supraglottic and transglottic carcinomas. Head Neck 1999;21: 694-702.

  35. Leon X, Quer M, Orus C et al. Selective dissection of levels II-III with intraoperative control of the upper and middle jugular nodes: a therapeutic option for the N0 neck. Head Neck 2001; 23 (6): 441-6.

  36. Brazilian Head and Neck Cancer Study Group. Results of a prospective trial on elective modified radical classical versus supraomohyoid neck dissection in the management of oral squamous carcinoma. Am J Surg 1998; 176: 422-7.

  37. Kolly VR, Datta RV, Orner JB et al. The role of supraomohyoid neck dissection in patients with positive nodes. Arch Otolaryngol Head Neck Surg 2000; 126 (3): 413-6.

  38. Chone CT, Silva AR, Crespo AN, Schlupp WR. Regional tumour recurrence after supraomohyoid neck dissection. Arch Otolaryngol Head Neck Surg 2003; 129 (1): 54-8.

  39. Hao SP, Tsang NM. The role of supraomohyoid neck dissection in patients of oral cavity. Oral Oncol 2002; 38 (3): 309-12.

  40. Manni JJ, Van den Hoogen FJA. Supraomohyoid neck dissection with frozen section biopsy as a staging procedure in the clinically node-negative neck in carcinoma of the oral cavity. Am J Surg 1991; 162: 373-6.

  41. Crean SJ, Hoffman A, Potts J, Fardy MJ. Reduction of occult metastatic disease by extension of the supraomohyoid neck dissection to include level IV. Head Neck 2003; 25 (9): 758-62.

  42. Carvalho Al, Kowalski LP, Borges JA et al. Ipsilateral neck cancer recurrences after elective supraomohyoid neck dissection. Arch Otolaringol Head Neck Surg 2000; 126 (3): 410-2.

  43. Chone CT, Silva AR, Crespo AN, Schlupp WR. Regional tumor recurrence after supraomohyoid neck dissection. Arch Otolaryngol Head Neck Surg 2003; 129 (1): 54-8.

  44. Franceschi D, Gupta R, Spiro RH, Shah JP. Improved survival in the treatment of squamous carcinoma of the oral tongue. Am J Surg 1993; 166 (4): 360-5.

  45. Godden DR, Ribeiro NF, Hassanein K, Langton SG. Recurrent neck disease in oral cancer. J Oral Maxillofac Surg 2002; 60 (7): 748-53.




2020     |     www.medigraphic.com